Royce & Associates’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-789,227
| Closed | -$8.98M | – | 912 |
|
|
2024
Q3 | $8.98M | Buy |
789,227
+57,111
| +8% | +$650K | 0.08% | 339 |
|
|
2024
Q2 | $5.23M | Buy |
732,116
+93,816
| +15% | +$670K | 0.05% | 470 |
|
|
2024
Q1 | $4.28M | Buy |
638,300
+140,230
| +28% | +$940K | 0.04% | 529 |
|
|
2023
Q4 | $3.24M | Buy |
498,070
+220,070
| +79% | +$1.43M | 0.03% | 576 |
|
|
2023
Q3 | $2.62M | Sell |
278,000
-25,000
| -8% | -$236K | 0.03% | 609 |
|
|
2023
Q2 | $4.23M | Hold |
303,000
| – | – | 0.04% | 532 |
|
|
2023
Q1 | $5.68M | Buy |
303,000
+47,000
| +18% | +$882K | 0.06% | 454 |
|
|
2022
Q4 | $3.53M | Buy |
256,000
+41,600
| +19% | +$573K | 0.04% | 557 |
|
|
2022
Q3 | $4.1M | Sell |
214,400
-115,300
| -35% | -$2.2M | 0.05% | 487 |
|
|
2022
Q2 | $5.03M | Sell |
329,700
-48,500
| -13% | -$740K | 0.05% | 472 |
|
|
2022
Q1 | $7.7M | Buy |
378,200
+189,500
| +100% | +$3.86M | 0.07% | 433 |
|
|
2021
Q4 | $5.51M | Sell |
188,700
-38,900
| -17% | -$1.14M | 0.04% | 545 |
|
|
2021
Q3 | $4.91M | Sell |
227,600
-3,400
| -1% | -$73.3K | 0.04% | 587 |
|
|
2021
Q2 | $5.93M | Sell |
231,000
-44,200
| -16% | -$1.13M | 0.04% | 569 |
|
|
2021
Q1 | $5.02M | Sell |
275,200
-3,300
| -1% | -$60.2K | 0.03% | 596 |
|
|
2020
Q4 | $3.21M | Buy |
278,500
+21,500
| +8% | +$248K | 0.03% | 644 |
|
|
2020
Q3 | $1.96M | Hold |
257,000
| – | – | 0.02% | 682 |
|
|
2020
Q2 | $1.69M | Sell |
257,000
-42,000
| -14% | -$276K | 0.02% | 703 |
|
|
2020
Q1 | $1.53M | Sell |
299,000
-35,000
| -10% | -$179K | 0.02% | 656 |
|
|
2019
Q4 | $2.56M | Hold |
334,000
| – | – | 0.02% | 648 |
|
|
2019
Q3 | $1.77M | Buy |
334,000
+34,000
| +11% | +$180K | 0.02% | 728 |
|
|
2019
Q2 | $1.68M | Buy |
+300,000
| New | +$1.68M | 0.02% | 758 |
|